Snowball logo
logo
NVSE_logo

Novartis AG

$157.90$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
52,87751,82846,66051,72257,126.454,748.8
COGS
15,86715,48612,02012,82714,26814,077.4
Gross Profit
37,01036,34234,64038,89542,858.440,671.4
Operating Expenses & Income
Operating Income
11,6899,1979,76914,54417,795.216,572.3
Total Operating Expenses
25,32127,14524,87124,35125,063.224,325.6
R&D Expenses
9,5409,99611,37110,02211,195.411,240.6
Selling General & Admin Expenses
14,88614,25312,51712,56613,2489,888
Earnings from Continuing Operations
Interest Expense
(906.9)(860.3)(855)(1,005.6)(1,237.2)(1,375.5)
Interest Income
71379627568373-
Income Tax Expense
2,1191,4165511,7012,498.52,745.9
Net Income
Net Income
24,0216,95514,85011,94114,649.312,642.8
Supplemental
EBIT
11,727.98,284.110,683.314,64618,379.717,177.9
EBITDA
17,168.415,209.119,517.820,71523,95822,685.5
In millions of USD, except % and values per 1 share